Aceto Corp (ACET):企業の財務・戦略的SWOT分析

【英語タイトル】Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C7721)・商品コード:DATA904C7721
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:53
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥54,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Aceto Corp (ACET) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aceto Corp (Aceto) is a distribution company that develops, markets, sells and distributes pharmaceutical intermediates, human health products and performance chemical products. The company’s product portfolio includes finished dosage form generic pharmaceuticals, pharmaceutical active ingredients and intermediates, nutraceutical products, specialty performance chemicals including agricultural protection products and agricultural intermediates. It distributes several chemical compounds used primarily as finished products or raw materials in the agricultural, pharmaceutical, nutraceutical, coatings and industrial chemical industries. The company operates subsidiaries in the US, Germany, Luxembourg, China, the Netherlands, France, France, Hong Kong, Singapore, India, the UK and Philippines. Aceto is headquartered in Port Washington, New York, the US.

Aceto Corp Key Recent Developments

Sep 28,2018: ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results
Sep 12,2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine - GNW]
Jul 16,2018: ACETO subsidiary Acetris Health receives favorable ruling regarding certain government contracts
Jun 22,2018: ACETO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Aceto
Jun 01,2018: Alan Levin Elected Chairman of the Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Aceto Corp – Key Facts 6
Aceto Corp – Key Employees 7
Aceto Corp – Key Employee Biographies 8
Aceto Corp – Major Products and Services 9
Aceto Corp – History 10
Aceto Corp – Company Statement 12
Aceto Corp – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
Aceto Corp – Business Description 17
Business Segment: Human Health Segment 17
Overview 17
Performance 17
Business Segment: Performance Chemicals Segment 17
Overview 17
Performance 17
Business Segment: Pharmaceutical Ingredients Segment 17
Overview 17
Performance 17
R&D Overview 18
Aceto Corp – Corporate Strategy 19
Aceto Corp – SWOT Analysis 20
SWOT Analysis – Overview 20
Aceto Corp – Strengths 20
Aceto Corp – Weaknesses 21
Aceto Corp – Opportunities 22
Aceto Corp – Threats 23
Aceto Corp – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
Aceto Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33
Aceto Corp, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Sep 28, 2018: ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results 35
Sep 12, 2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine - GNW] 38
Sep 12, 2018: ACETO Announces Credit Agreement Amendment[Newswire : MarketLine - GNW] 39
Jul 16, 2018: ACETO subsidiary Acetris Health receives favorable ruling regarding certain government contracts 40
Jun 22, 2018: ACETO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Aceto 41
Jun 01, 2018: Alan Levin Elected Chairman of the Board of Directors 42
May 03, 2018: ACETO Reports Fiscal 2018 Third Quarter Results 43
Apr 18, 2018: ACETO Board Takes Proactive Steps to Address Business and Financial Challenges 45
Feb 27, 2018: ACETO to Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts 46
Feb 01, 2018: ACETO Reports Fiscal 2018 Second Quarter Results 47
Section 6 – Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Aceto Corp, Key Facts 6
Aceto Corp, Key Employees 7
Aceto Corp, Key Employee Biographies 8
Aceto Corp, Major Products and Services 9
Aceto Corp, History 10
Aceto Corp, Subsidiaries 14
Aceto Corp, Key Competitors 24
Aceto Corp, Ratios based on current share price 25
Aceto Corp, Annual Ratios 26
Aceto Corp, Annual Ratios (Cont...1) 27
Aceto Corp, Annual Ratios (Cont...2) 28
Aceto Corp, Interim Ratios 30
Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
Aceto Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33
Aceto Corp, Recent Deals Summary 34
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List of Figures
Aceto Corp, Performance Chart (2013 - 2017) 29
Aceto Corp, Ratio Charts 31
Aceto Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32
Aceto Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

★調査レポート[Aceto Corp (ACET):企業の財務・戦略的SWOT分析] (コード:DATA904C7721)販売に関する免責事項を必ずご確認ください。
★調査レポート[Aceto Corp (ACET):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆